| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Barbara Yanni | Director | Jun 23, 2022 | |||
| James E. Flynn | Possible Member of 10% Group, 10%+ Owner | Dec 28, 2022 | |||
| Mary Kay Fenton | Director | Jun 23, 2022 | |||
| Rick Wanstall | CFO and Treasurer | May 25, 2022 | |||
| Douglas Fambrough | Director | Jun 22, 2022 | |||
| Mitchell H. Finer | Director | Jun 23, 2022 | |||
| Theodore Ashburn | President and CEO, Director | Mar 1, 2022 | |||
| John P. McCabe | CFO and Treasurer | Mar 1, 2022 | |||
| Christophe Queva | CSO and SVP, Research | Mar 1, 2022 | |||
| Stephen Harbin | COO and Chief of Staff | Nov 1, 2022 | |||
| Eric Rubin | Director | Jun 23, 2022 | |||
| Spencer Nam | Director | Jun 23, 2022 | |||
| John Mayer Goldberg | Chief Medical Officer | Mar 1, 2022 | |||
| Brian J. Shea | Interim CEO | Jun 6, 2023 | |||
| Luke Evnin | Director | Jun 23, 2022 | |||
| Scott A. Canute | Director | Jun 23, 2022 | |||
| Alexander Nolte | Interim CFO | May 9, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|